Making Sense of Severe Lupus: How the SLE-DAS Tool Could Improve Care Outcomes

Inside Lupus: The Potential of Genetic Endotypes to Personalize Lupus Care

Empowering Lupus Patients: A Treatment Measure Shaped by Their Voices

Steroid Use for the Treatment of Lupus Nephritis

Validating Claims Algorithms for SLE: Geospatial Insights and Impacts on Health Disparities

Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids

Rituximab in Childhood Lupus: Insights and Safety

Managing Pregnancy in Lupus: Contraception Use and Beyond

Leveraging Positive Psychosocial Factors to Manage Stress in Lupus

Krill Oil may represent a promising complementary therapy in SLE

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

Interpreting Hydroxychloroquine Blood Levels in Lupus

Use of Artificial Intelligence and Machine Learning in Clinical Practice

To RNase or Not to RNase: That Is the Question

A decision-aid facilitates patient understanding of benefits vs. risk of hydroxychloriquine use as part of routine care for lupus

Dual dsDNA testing may be needed to fully understand patient disease status

Is Anifrolumab an effective treatment for lupus nephritis?

Which one is better at controlling lupus: Belimumab or Anifrolumab?

Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis

Testing a new measure of lupus improvement that encompasses the patients’ perspectives and doctors’ evaluations